Formycon AG (ETR:FYB)
17.88
-0.14 (-0.78%)
Apr 29, 2026, 5:35 PM CET
Formycon AG Revenue
In the year 2025, Formycon AG had annual revenue of 44.48M EUR, down -36.17%. Formycon AG had revenue of 24.98M in the quarter ending December 31, 2025, a decrease of -12.59%.
Revenue
44.48M
Revenue Growth
-36.17%
P/S Ratio
7.16
Revenue / Employee
177.90K
Employees
245
Market Cap
318.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 44.48M | -25.20M | -36.17% |
| Dec 31, 2024 | 69.67M | -8.02M | -10.32% |
| Dec 31, 2023 | 77.70M | 35.20M | 82.83% |
| Dec 31, 2022 | 42.50M | 5.88M | 16.07% |
| Dec 31, 2021 | 36.61M | 2.32M | 6.76% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Merck KGaA | 21.10B |
| Siemens Healthineers AG | 23.30B |
| Bayer Aktiengesellschaft | 45.58B |
| Fresenius SE & Co. KGaA | 22.87B |
| RHÖN-KLINIKUM Aktiengesellschaft | 1.97B |
| Medios AG | 2.08B |
| M1 Kliniken AG | 354.98M |
| Stratec SE | 250.86M |
Formycon AG News
- 6 days ago - Formycon AG (XTER:FYB) Full Year 2025 Earnings Call Highlights: Transformational Year with ... - GuruFocus
- 6 days ago - Full Year 2025 Formycon AG Earnings Call Transcript - GuruFocus
- 7 days ago - Formycon AG Earnings Call Transcript: Q4 2025 - Transcripts
- 7 days ago - EQS-News: Formycon reports successful financial year 2025 with important operational progress, growing market presence and strategic partnerships - Wallstreet:Online
- 9 days ago - EQS-News: Formycon invites to Conference Call on the Results of the Financial Year 2025 and announces Participation in international Investor Conferences in the 2nd Quarter of 2026 - Wallstreet:Online
- 13 days ago - EQS-AFR: Formycon AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - Wallstreet:Online
- 14 days ago - Formycon AG: Unlocking Breakthrough Biotech Innovations - Wallstreet:Online
- 14 days ago - EQS-Adhoc: Formycon AG: - Wallstreet:Online